The global Endoscopic Hemostasis Devices Market size was valued at USD 2,066.92 million in 2024 and is projected to reach USD 2,954.80 million by 2034, growing at a CAGR of 3.6% during the forecast period of 2025–2034. This steady expansion is primarily fueled by the rising prevalence of gastrointestinal disorders and the increasing need for effective endoscopic hemostasis devices to manage internal bleeding complications. According to a March 2021 IARC report, GI cancers account for 25% of global cancer cases (4.8 million) and 33% of cancer deaths, underscoring the substantial worldwide burden of these conditions. Disorders such as peptic ulcers and inflammatory bowel disease frequently lead to severe bleeding episodes, making the gastrointestinal bleeding treatment devices market a critical component of modern healthcare infrastructure.

As the global patient population grows, clinical reliance on reliable endoscopic bleeding control devices becomes increasingly vital. These tools ensure timely intervention, reduce the need for invasive surgeries, and improve patient outcomes. The broader GI endoscopy devices market growth is also being propelled by continuous product innovation and favorable government initiatives promoting cancer screening programs. Within this landscape, the hemostatic clips market plays a pivotal role. For instance, Boston Scientific’s Resolution 360 Clip system is engineered for precise placement and strong retention across the entire GI tract. Similarly, in January 2022, Cook Medical launched the Instinct Plus Endoscopic Clipping Device in the US, featuring improved handling and expanded indications for defect closure.

Read More @ https://www.polarismarketresearch.com/industry-analysis/endoscopic-hemostasis-devices-market

Technological enhancements further support this trajectory. In September 2022, Medtronic received FDA clearance for Nexpowder, an endoscopic hemostasis system developed by NEXTBIOMEDICAL that treats upper GI bleeding, addressing over 1 million annual hemostasis procedures in the US. Furthermore, in May 2025, Olympus launched its OLYSENSE Platform integrated with the CADDIE AI device, assisting gastroenterologists in detecting suspected polyps during colonoscopies. North America dominated the revenue share in 2024 due to its advanced healthcare infrastructure, while the Asia Pacific region is projected to witness the fastest growth, driven by expanding healthcare capacity in countries like China, India, and Japan. Ultimately, the integration of these life-saving devices continues to redefine gastrointestinal care globally.

More Trending Latest Reports By Polaris Market Research:

Hotel Management Software Market

Europe Point of Care (PoC) Diagnostics Market

Data Center Liquid Cooling Market

US Biomarkers Market

Protein Labelling Market

Cosmetic Surgery Market

Microcatheter Market

Asphalt Release Agents Market

Fatty Acid Esters Market